Combined Laparoscopic and CT Monitoring of the Ice-Ball Margin during Cryoablation for Renal Cell Carcinoma Associated with von Hippel-Lindau Disease: First Case.


Journal

Acta medica Okayama
ISSN: 0386-300X
Titre abrégé: Acta Med Okayama
Pays: Japan
ID NLM: 0417611

Informations de publication

Date de publication:
Oct 2020
Historique:
entrez: 27 10 2020
pubmed: 28 10 2020
medline: 14 7 2021
Statut: ppublish

Résumé

We report a 47-year-old Japanese female with 10 previous treatments for multiple bilateral renal cell carcinoma (RCC) associated with von Hippel-Lindau disease. The 14-mm right lower pole renal tumor was in contact with the right ureter. Laparoscopic cryoablation was performed to protect the ureter wrapped with gauze. Computed tomography (CT) monitoring was used to confirm the precise ≥ 6 mm ice-ball margin. There was no local progression at 6-months post-surgery. The serum creatinine has been stable. This is apparently the first report of combined laparoscopic and CT monitoring of an ice-ball formation and its margin during cryoablation for RCC.

Identifiants

pubmed: 33106702
doi: 10.18926/AMO/60806
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

443-448

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

No potential conflict of interest relevant to this article was reported.

Références

Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, M Piñeros, Znaor A and Bray F: Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer (2019) 144: 1941-1953.
Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Kuusk T, Lam TB, Marconi L, Merseburger AS, Powles T, Staehler M, Tahbaz R, Volpe A and Bex A: European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. Eur Urol (2019) 75: 799-810.
Bausch B, Jilg C, Gläsker S, Vortmeyer A, Lützen N, Anton A, Eng C and Neumann HP: Renal cancer in von Hippel-Lindau disease and related syndromes. Nat Rev Nephrol (2013) 9: 529-538.
Maher ER, Iselius L, Yates JR, Littler M, Benjamin C, Harris R, Sampson J, Williams A, Ferguson-Smith MA and Morton N: Von Hippel-Lindau disease: a genetic study. J Med Genet (1991) 28: 443-447.
Neumann HP and Wiestler OD: Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet (1991) 337: 1052-1054.
Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM and Oldfield EH: von Hippel-Lindau disease. Lancet (2003) 361: 2059-2067.
Neumann HP, Lips CJ, Hsia YE and Zbar B: Von Hippel-Lindau syndrome. Brain Pathol (1995) 5: 181-193.
Gallou C, Chauveau D, Richard S, Joly D, Giraud S, Olschwang S, Martin N, Saquet C, Chrétien Y, Méjean A, Correas JM, Benoît G, Colombeau P, Grünfeld JP, Junien C and Béroud C: Genotypephenotype correlation in von Hippel-Lindau families with renal lesions. Hum Mutat (2004) 24: 435-436.
Binderup ML, Jensen AM, Budtz-Jørgensen E and Bisgaard ML: Survival and causes of death in patients with von Hippel-Lindau disease. J Med Genet (2017) 54: 11-18.
Cheng Z, Yu X, Han Z, Liu F, Yu J and Liang P: Ultrasound-guided hydrodissection for assisting percutaneous microwave ablation of renal cell carcinomas adjacent to intestinal tracts: a preliminary clinical study. Int J Hyperthermia (2018) 34: 315-320.
Bodily KD, Atwell TD, Mandrekar JN, Farrell MA, Callstrom MR, Schmit GD and Charboneau JW: Hydrodisplacement in the percutaneous cryoablation of 50 renal tumors. Am J Roentgenol (2010) 194: 779-783.
Matin SF, Ahrar K, Wood CG, Daniels M and Jonasch E: Patterns of intervention for renal lesions in von Hippel-Lindau disease. BJU Int (2008) 102: 940-945.
Ryan DW, Hajime T, Steven CC and Erick MR: 2017 AUA Renal Mass and Localized Renal Cancer Guidelines: Imaging Implications. Radiographics (2018) 38: 2021-2033.
Pessoa RR, Autorino R, Laguna MP, Molina WR, Gustafson D, Nogueira L, Silva RD, Werahera PN and Kim FJ: Laparoscopic versus percutaneous cryoablation of small renal mass: systematic review and cumulative analysis of comparative studies. Clin Genitourin Cancer (2017) 15: 513-519.
Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P and Uzzo RG: Guideline for management of the clinical T1 renal mass. J Urol (2009) 182: 1271-1279.
Nielsen TK, Lagerveld BW, Keeley F, Lughezzani G, Sriprasad S, Barber NJ, Hansen LU, Buffi NM, Guazzoni G, Zee JA, Ismail M, Farrag K, Emara AM, Lund L, Østraat Ø and Borre M: Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study. BJU Int (2017) 119: 390-395.
Gill IS, Novick AC, Soble JJ, Sung GT, Remer EM, Hale J and OʼMalley CM: Laparoscopic renal cryoablation: initial clinical series. Urology (1998) 52: 543-551.
Klatte T, Grubmüller B, Waldert M, Weibl P and Remzi M: Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol (2011) 60: 435-443. 19. Klatte T, Shariat SF and Remzi M: Systematic review and
Klatte T, Shariat SF and Remzi M: Systematic review and meta-analysis of perioperative and oncologic outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors. J Urol (2014) 191: 1209-1217.
Larcher A, Fossati N, Mistretta F, Lughezzani G, Lista G, DellʼOglio P, Abrate A, Sun M, Karakiewicz P, Suardi N, Lazzeri M, Montorsi F, Guazzoni G and Buffi N: Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses. Urol Oncol (2015) 33: 22.
Allen BC and Remer EM: Percutaneous cryoablation of renal tumors: patient selection, technique, and postprocedural imaging. Radiographics (2010) 30: 887-900.
Deng W, Chen L, Wang Y, Liu X, Wang G, Liu W, Zhang C, Zhou X, Li Y and Fu B: Cryoablation versus Partial Nephrectomy for Clinical Stage T1 Renal Masses: A Systematic Review and Meta-Analysis. J Cancer (2019) 10: 1226-1236.
Chang X, Liu T, Zhang F, Cheng Q, Changwei J, Xiaozhi Z, Guangxiang L and Hongqian G: The comparison of R.E.N.A.L., PADUA and centrality index score in predicting perioperative outcomes and complications after laparoscopic radio frequency ablation of renal tumors. J Urol (2015) 194: 897-902.

Auteurs

Takanori Sekito (T)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Motoo Araki (M)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Takao Hiraki (T)

Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Mayu Uka (M)

Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Toshiyuki Komaki (T)

Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Yusuke Matsui (Y)

Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Toshihiro Iguchi (T)

Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Satoshi Katayama (S)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Kasumi Yoshinaga (K)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Shogo Watari (S)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Yuki Maruyama (Y)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Yosuke Mitsui (Y)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Risa Kubota (R)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Takuya Sadahira (T)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Shingo Nishimura (S)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Koichiro Wada (K)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Atsushi Takamoto (A)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Kohei Edamura (K)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Tomoko Sako (T)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Yasuyuki Kobayashi (Y)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Toyohiko Watanabe (T)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Susumu Kanazawa (S)

Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Yasutomo Nasu (Y)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH